Article Details
Retrieved on: 2022-06-27 16:49:10
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca (GB:AZN) announced that Daiichi Sankyo and AstraZeneca's trastuzumab deruxtecan, also known as Enhertu, has been recommended for ...
Article found on: www.tipranks.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here